Enterprise agreements include unlimited access to BIM quality assurance software
Solibri has announced a trio of enterprise software agreements with leading AEC firms in Northern Europe. Professional services business WSP, Nordic construction company Peab and the Construction & Real Estate (C&RED) division of VolkerWessels will all get unlimited access to Solibri’s BIM quality assurance software.
VolkerWessels C&RED, headquartered in the Netherlands, will use Solibri’s automated checking software for its largest projects.
“By choosing Solibri, we are happy in the knowledge that we are doing everything to build correctly and efficiently,” said Bas Wiggers, Teamleader Service Management, Managed Services at VolkerWessels C&RED.
Ville Kyytsönen, Solibri CEO added, “Our role is to offer solutions that help our customers to deliver projects in time, within budget and the expected quality. VolkerWessels C&RED understands that the workflow needs quality assurance and control throughout the process.
“By applying Solibri properly, you can pass on those benefits not just in terms of financial efficiencies but also have a real positive environmental impact. It is important that forward thinking companies implement BIM tools with deep capability instead of just good-enough-viewers.”
WSP’s agreement with Solibri will cover the Nordic region, including Finland, Sweden, Norway, and Denmark and include unlimited access to Solibri’s BIM quality assurance and control solutions.
Peab, the Nordic construction firm that operates in Sweden, Finland, Norway and Denmark, will get unlimited access to Solibri Office, Solibri’s core product for model checking and collaboration.
Solibri Enterprise Agreements are designed for large customers with multiple Solibri users and projects and offers unlimited concurrent license usage with global support when needed, for a fixed annual baseline cost with multi-year contract.
Meanwhile, check out this AEC Magazine article where we caught up with Simon Gilbert of Solibri UK to discuss common issues surrounding the production of COBie and why it seems so painful for many.